ArticleOncology letters2021

Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population.

Na-Yon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.